P1.12B.05 Patient and Oncologist Preferences for ALK+ Advanced Non-Small Cell Lung Cancer Tyrosine Kinase Inhibitor Treatments

Autor: Le, H., Coulter, J., Cappelleri, J.C., Lu, H., Quaife, M., Meginnis, K., Fernandez, G., Culver, K., Vaghela, S., Rifi, N., Stinchcombe, T.
Zdroj: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S202-S202
Databáze: ScienceDirect